Editorial Article: Meet the winners of the 2021 Scientists’ Choice Awards for Drug Discovery & Development

Scientific, technological and communications excellence has been celebrated at the Drug Discovery & Development Webinar Series, with Waters, BioTek and PHCbi among those recognized

29 Apr 2021



Cytation™ 7 Cell Imaging Multi-Mode Reader from BioTek Instruments is the winner of Best New Drug Discovery & Development Product of 2020

The world’s most innovative and effective new drug discovery and development technologies have been recognized at the SelectScience® Webinar Series: Drug Discovery & Development. Winners of the 2021 Scientists’ Choice Awards® were announced live by SelectScience CEO Kerry Parker and Editor Dr. Lois Manton-O'Byrne to an online audience of industry leaders and scientists. 

Now in their 14th year, the awards are unique in the industry as they are chosen by scientists. Each year, we invite scientists around the globe to participate by nominating, reviewing and voting for the lab products that have had the greatest impact on their work. This year, more scientists than ever got involved — read on to reveal their chosen winners. 

Best New Drug Discovery & Development Product of 2020

The award for Best New Drug Discovery & Development Product of 2020 goes to the Cytation™ 7 Cell Imaging Multi-Mode Reader from BioTek Instruments, as voted for by scientists around the world. 

BioTek produced a multi-mode reader with sophisticated imaging for fluorescence, brightfield, color brightfield, upright reflected brightfield applications. The Cytation™ 7 Cell Imaging Multi-Mode Reader combines automated digital upright and inverted widefield microscopy with conventional multi-mode microplate reading in a unique, patented design.

Your runners-up are: 

Drug Discovery & Development Video Interview of the Year – in association with The Scientists’ Channel 

This year’s winning video ‘Supporting science: Discover the technology enabling innovation communities in bioscience’ is an interview with Susie Harborth, Executive Vice President at Breakthrough Properties. 

In this video, Harborth explains how a collaboration with PHCbi has been critical to her company's goal of delivering high-quality resources and environments that enable scientists to develop pioneering therapies, diagnostics and vaccinations. 

Drug Discovery & Development Application eBook of the Year

The Drug Discovery & Development eBook of the Year Award goes to Horizon Discovery for ‘Advances in CRISPR-Cas9 gene editing and screening technology'. This application compendium presents a guide to gene editing and functional genomics screening using Horizon Discovery’s Edit-R™ CRISPR genome engineering platform. 

“We’re most appreciative of you selecting Horizon’s eBook, Advances in CRISPR-Cas9 gene editing and screening technology, as the winner in this category.  We feel particularly honored to support the research, drug discovery and development community during these extraordinary times.”
David Stegemeier, Product Marketing Specialist, Horizon Discovery

Drug Discovery & Development Editorial Article of the Year 

This year’s winning article is titled ‘Clinical proteomics: Identifying biomarkers to predict patient risk of COVID-19’ and featured technology from Olink Proteomics

In an exclusive interview, Prof. Leo Joosten, Head of Research, Department of Experimental Medicine, and Professor of Mechanisms of Inflammatory Disease at Radboudumc, Nijmegen, The Netherlands, discusses how his team is working to identify biomarkers of the disease, its mechanisms of infection and the impact of immune response, to ultimately search for possible treatments and vaccination approaches. 

Drug Discovery & Development Webinar of the Year

This year’s Webinar of the Year is presented by Dr. Mark Argentine, Senior Research Advisor Lilly Research Laboratories at  Eli Lilly and Company, in collaboration with Waters Corporation

The webinar, titled ‘Developing impurities analytical methods with a quality by design approach’ and available to watch on demand, is intended as a masterclass in how risk-based approaches such as Analytical Quality by Design (AQbD) and Method Lifecycle Management (MLCM) can be implemented to develop fit-for-purpose and robust methods that improve the control of impurities.

Drug Discovery & Development Email of the Year

The winner in the Email of the Year category goes to ‘New poster: The periodic table of antibodies', from Sartorius. The winning email featured a free download of the 'Periodic Table of Antibodies' and proved hugely popular with the SelectScience audience of scientists around the world.

Want to share your opinion on the drug discovery & development products in your lab? Leave a review now and you could win an iPad or $400 Amazon gift card >>